Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.075 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |